2020
DOI: 10.1016/j.ajo.2020.05.036
|View full text |Cite
|
Sign up to set email alerts
|

Choroidal Thickness in Diabetic Patients Without Diabetic Retinopathy: A Meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
30
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(31 citation statements)
references
References 50 publications
0
30
1
Order By: Relevance
“…Using these machines, many studies have shown a significant difference in choroidal thickness (CT) of diabetic eyes compared to healthy eyes [ 13 16 ]. However, the findings of these studies were mostly controversial and inconsistent, especially in patients without DR [ 17 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…Using these machines, many studies have shown a significant difference in choroidal thickness (CT) of diabetic eyes compared to healthy eyes [ 13 16 ]. However, the findings of these studies were mostly controversial and inconsistent, especially in patients without DR [ 17 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…The SFChT changes in eyes with DR or diabetic eyes without DR have been intensely investigated by several studies [ 15 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ]. However, the relationship between DR severity and SFChT is controversial.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Wang et al reported an increase in SFChT in the early stage of DR, but this decreased with DR progression [ 45 ]. Moreover, Endo et al showed that the SFChT of eyes with severe NPDR was thicker than that of normal controls only in the DM treatment group [ 37 ]. Changes in choroidal vasculature have also been seen in patients with diabetes [ 10 ], and studies have demonstrated that CVI is significantly decreased with a worsened DR [ 10 , 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…In diabetic patients with diabetic retinopathy, the regular growth-based prognosis is a crucial and critical element of patient therapy. e cost of therapy is heavily influenced by the accuracy and timeliness of this care [11]. If discovered early, compensatory therapy for diabetic retinopathy is available, and it is a vital step.…”
Section: Introductionmentioning
confidence: 99%